医薬品サプライチェーンマネジメントの世界市場：予測（2023年～2032年）

世界の医薬品サプライチェーンマネジメントの市場規模は、2023年～2032年の予測期間中に8.84%のCAGRで拡大すると予測されています。市場の成長を後押しする主な促進要因としては、ヘルスケアにおけるクラウドコンピューティングシステムの適用拡大、GS1標準システムの採用、医療費削減への圧力の高まり、医薬品需要の急増、医薬品偽造の高い普及率などが挙げられます。

当レポートでは、世界の医薬品サプライチェーンマネジメント市場について調査し、市場の概要とともに、コンポーネント別、展開モード別、地域別の動向、競合情勢、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 調査範囲と調査手法

第2章 エグゼクティブサマリー

第3章 市場力学

• 主要な促進要因
• 主要な抑制要因

第4章 主要な分析

• 主要なテクノロジーの動向
• ポーターのファイブフォース分析
• 成長見通しのマッピング
• 市場集中分析
• 市場成熟度分析

第5章 コンポーネント別市場

• ソリューション
• サービス

第6章 展開モード別市場

• オンプレミス
• クラウドベース

第7章 地域別分析

• 北米
• 欧州
• アジア太平洋
• その他の地域

第8章 競合情勢

• 主要な戦略的展開
• 企業プロファイル
  • ARVATO SUPPLY CHAIN SOLUTIONS
  • CARDINAL HEALTH
  • EPICOR SOFTWARE CORPORATION
  • GLOBAL HEALTHCARE EXCHANGE LLC
  • INFOR
  • JUMP TECHNOLOGIES
  • LOGITAG SYSTEMS
  • MANHATTAN ASSOCIATES
  • MCKESSON CORPORATION
  • ORACLE CORPORATION
  • SAP SE
  • SPECTRUM HEALTH
  • TECSYS INC
  • TERSO SOLUTION
  • VIZIENT INC

LIST OF TABLES

• TABLE 1: MARKET SNAPSHOT - PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT
• TABLE 2: PRIMARY FACTORS CONTRIBUTING TO THE WIDESPREAD PRESENCE OF COUNTERFEIT GOODS
• TABLE 3: GLOBAL PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY COMPONENT, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
• TABLE 4: GLOBAL PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY COMPONENT, FORECAST YEARS, 2023-2032 (IN $ MILLION)
• TABLE 5: GLOBAL PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY SOLUTION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
• TABLE 6: GLOBAL PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY SOLUTION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
• TABLE 7: GLOBAL TRANSPORTATION MANAGEMENT SYSTEM MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
• TABLE 8: GLOBAL TRANSPORTATION MANAGEMENT SYSTEM MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
• TABLE 9: GLOBAL PLANNING & ANALYTICS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
• TABLE 10: GLOBAL PLANNING & ANALYTICS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
• TABLE 11: GLOBAL WAREHOUSE & INVENTORY MANAGEMENT SYSTEM MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
• TABLE 12: GLOBAL WAREHOUSE & INVENTORY MANAGEMENT SYSTEM MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
• TABLE 13: GLOBAL PROCUREMENT & SOURCING MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
• TABLE 14: GLOBAL PROCUREMENT & SOURCING MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
• TABLE 15: GLOBAL MANUFACTURING EXECUTION SYSTEM MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
• TABLE 16: GLOBAL MANUFACTURING EXECUTION SYSTEM MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
• TABLE 17: GLOBAL PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY SERVICE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
• TABLE 18: GLOBAL PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY SERVICE, FORECAST YEARS, 2023-2032 (IN $ MILLION)
• TABLE 19: GLOBAL PROFESSIONAL SERVICES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
• TABLE 20: GLOBAL PROFESSIONAL SERVICES MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
• TABLE 21: GLOBAL MANAGED SERVICES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
• TABLE 22: GLOBAL MANAGED SERVICES MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
• TABLE 23: GLOBAL PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
• TABLE 24: GLOBAL PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODE, FORECAST YEARS, 2023-2032 (IN $ MILLION)
• TABLE 25: GLOBAL ON-PREMISE MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
• TABLE 26: GLOBAL ON-PREMISE MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
• TABLE 27: GLOBAL CLOUD-BASED MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
• TABLE 28: GLOBAL CLOUD-BASED MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
• TABLE 29: GLOBAL PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
• TABLE 30: GLOBAL PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY GEOGRAPHY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
• TABLE 31: NORTH AMERICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
• TABLE 32: NORTH AMERICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
• TABLE 33: NORTH AMERICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET REGULATORY FRAMEWORK
• TABLE 34: KEY PLAYERS OPERATING IN NORTH AMERICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET
• TABLE 35: EUROPE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
• TABLE 36: EUROPE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
• TABLE 37: EUROPE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET REGULATORY FRAMEWORK
• TABLE 38: KEY PLAYERS OPERATING IN EUROPE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET
• TABLE 39: ASIA-PACIFIC PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
• TABLE 40: ASIA-PACIFIC PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
• TABLE 41: ASIA-PACIFIC PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET REGULATORY FRAMEWORK
• TABLE 42: KEY PLAYERS OPERATING IN ASIA-PACIFIC PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET
• TABLE 43: REST OF WORLD PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
• TABLE 44: REST OF WORLD PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
• TABLE 45: REST OF WORLD PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET REGULATORY FRAMEWORK
• TABLE 46: KEY PLAYERS OPERATING IN REST OF WORLD PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET
• TABLE 47: LIST OF PRODUCT LAUNCHES
• TABLE 48: LIST OF PARTNERSHIPS

LIST OF FIGURES

• FIGURE 1: KEY TECHNOLOGY TRENDS
• FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
• FIGURE 3: GROWTH PROSPECT MAPPING FOR NORTH AMERICA
• FIGURE 4: GROWTH PROSPECT MAPPING FOR EUROPE
• FIGURE 5: GROWTH PROSPECT MAPPING FOR ASIA-PACIFIC
• FIGURE 6: GROWTH PROSPECT MAPPING FOR REST OF WORLD
• FIGURE 7: MARKET MATURITY ANALYSIS
• FIGURE 8: MARKET CONCENTRATION ANALYSIS
• FIGURE 9: GLOBAL PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, GROWTH POTENTIAL, BY COMPONENT, IN 2022
• FIGURE 10: GLOBAL PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY SOLUTION, 2023-2032 (IN $ MILLION)
• FIGURE 11: GLOBAL PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, GROWTH POTENTIAL, BY SOLUTION, IN 2022
• FIGURE 12: GLOBAL PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY TRANSPORTATION MANAGEMENT SYSTEM, 2023-2032 (IN $ MILLION)
• FIGURE 13: GLOBAL PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY PLANNING & ANALYTICS, 2023-2032 (IN $ MILLION)
• FIGURE 14: GLOBAL PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY WAREHOUSE & INVENTORY MANAGEMENT SYSTEM, 2023-2032 (IN $ MILLION)
• FIGURE 15: GLOBAL PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY PROCUREMENT & SOURCING, 2023-2032 (IN $ MILLION)
• FIGURE 16: GLOBAL PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY MANUFACTURING EXECUTION SYSTEM, 2023-2032 (IN $ MILLION)
• FIGURE 17: GLOBAL PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY SERVICE, 2023-2032 (IN $ MILLION)
• FIGURE 18: GLOBAL PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, GROWTH POTENTIAL, BY SERVICE, IN 2022
• FIGURE 19: GLOBAL PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY PROFESSIONAL SERVICES, 2023-2032 (IN $ MILLION)
• FIGURE 20: GLOBAL PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY MANAGED SERVICES, 2023-2032 (IN $ MILLION)
• FIGURE 21: GLOBAL PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, GROWTH POTENTIAL, BY DEPLOYMENT MODE, IN 2022
• FIGURE 22: GLOBAL PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY ON-PREMISE, 2023-2032 (IN $ MILLION)
• FIGURE 23: GLOBAL PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY CLOUD-BASED, 2023-2032 (IN $ MILLION)
• FIGURE 24: GLOBAL PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, REGIONAL OUTLOOK, 2022 & 2032 (IN %)
• FIGURE 25: NORTH AMERICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN %)
• FIGURE 26: UNITED STATES PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, 2023-2032 (IN $ MILLION)
• FIGURE 27: CANADA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, 2023-2032 (IN $ MILLION)
• FIGURE 28: EUROPE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN %)
• FIGURE 29: UNITED KINGDOM PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, 2023-2032 (IN $ MILLION)
• FIGURE 30: GERMANY PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, 2023-2032 (IN $ MILLION)
• FIGURE 31: FRANCE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, 2023-2032 (IN $ MILLION)
• FIGURE 32: ITALY PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, 2023-2032 (IN $ MILLION)
• FIGURE 33: SPAIN PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, 2023-2032 (IN $ MILLION)
• FIGURE 34: NORDIC COUNTRIES PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, 2023-2032 (IN $ MILLION)
• FIGURE 35: REST OF EUROPE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, 2023-2032 (IN $ MILLION)
• FIGURE 36: ASIA-PACIFIC PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN %)
• FIGURE 37: CHINA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, 2023-2032 (IN $ MILLION)
• FIGURE 38: JAPAN PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, 2023-2032 (IN $ MILLION)
• FIGURE 39: INDIA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, 2023-2032 (IN $ MILLION)
• FIGURE 40: SOUTH KOREA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, 2023-2032 (IN $ MILLION)
• FIGURE 41: AUSTRALIA & NEW ZEALAND PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, 2023-2032 (IN $ MILLION)
• FIGURE 42: REST OF ASIA-PACIFIC PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, 2023-2032 (IN $ MILLION)
• FIGURE 43: REST OF WORLD PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, REGIONAL OUTLOOK, 2022 & 2032 (IN %)
• FIGURE 44: LATIN AMERICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, 2023-2032 (IN $ MILLION)
• FIGURE 45: MIDDLE EAST & AFRICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, 2023-2032 (IN $ MILLION)

KEY FINDINGS

The global pharmaceutical supply chain management market is anticipated to grow with a CAGR of 8.84% during the forecast period, 2023 to 2032. Some of the top factors bolstering the market's growth include the increasing application of cloud computing systems in healthcare, the adoption of the GS1 standard system, the mounting pressure to reduce healthcare costs, the surging demand for pharmaceutical products, and the high prevalence of drug counterfeiting.

MARKET INSIGHTS

Pharmaceutical supply chain management (SCM) software facilities the implementation, planning, as well as control of pharmaceutical product flow from the point of origin to consumption. The supply chain in the pharmaceutical industry includes the movement of active ingredients, finished products, raw materials, as well as medical devices from manufacturers to distributors, pharmacies, healthcare facilities, and wholesalers.

The surging incidence of drug counterfeiting in the pharmaceutical industry has generated an increasing need for effective supply chain management solutions. Furthermore, drug counterfeiting is a global problem that poses a substantial threat to public health. Counterfeit drugs may also comprise incorrect doses and harmful substances, resulting in serious health consequences like the failure of treatments or cures, increased risk of prolonged illness, and/or death.

As per the estimations issued by the Pharmaceutical Security Institute, incidents of counterfeit medicine trafficking have heightened significantly, with a 38% rise from 3146 in 2016 to 4344 in 2020 across 137 nations. Besides, in 2020, 2451 different drugs from all therapeutic categories were involved. Hence, the pharmaceutical industry is under tremendous pressure to implement measures that ensure drug safety and authenticity throughout the supply chain, thus propelling the global pharmaceutical supply chain management market growth during the forecasted period.

REGIONAL INSIGHTS

The global pharmaceutical supply chain management market growth analysis entails the study of the Asia-Pacific, North America, Europe, and Rest of World. Asia-Pacific is projected to rise with the highest CAGR during the forecast period. The region's market growth is credited to the increased Internet and mobile device adoption, the sizable pharmaceutical industry in the Asia-Pacific, and the surging adoption of advanced technologies.

COMPETITIVE INSIGHTS

The competition in the global pharmaceutical supply chain management market is set to be high during the projection period. In addition, key players operating in the global market are McKesson Corporation, Tecsys Inc, Infor, etc.

Our report offerings include:

• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation caters to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• The competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

• 1.1. STUDY OBJECTIVES
• 1.2. METHODOLOGY
• 1.3. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

• 2.1. MARKET SIZE & ESTIMATES
• 2.2. MARKET OVERVIEW
• 2.3. SCOPE OF STUDY
• 2.4. CRISIS SCENARIO ANALYSIS

3. MARKET DYNAMICS

• 3.1. KEY DRIVERS
  • 3.1.1. INCREASING APPLICATION OF CLOUD COMPUTING SYSTEMS IN HEALTHCARE
  • 3.1.2. ADOPTION OF GS1 STANDARD SYSTEM
  • 3.1.3. GROWING PRESSURE TO REDUCE HEALTHCARE COSTS
  • 3.1.4. SURGING DEMAND FOR PHARMACEUTICALS PRODUCTS
  • 3.1.5. HIGH PREVALENCE OF DRUG COUNTERFEITING
• 3.2. KEY RESTRAINTS
  • 3.2.1. STRINGENT REGULATIONS IN HEALTHCARE DATA EXCHANGE
  • 3.2.2. HIGH OPERATIONAL COSTS OF HEALTHCARE SCM SOFTWARE
  • 3.2.3. TECHNICAL PROBLEMS ASSOCIATED WITH SCM SOFTWARE
  • 3.2.4. SECURITY ISSUES IN WEAK SCM LINKS

4. KEY ANALYTICS

• 4.1. KEY TECHNOLOGY TRENDS
• 4.2. PORTER'S FIVE FORCES ANALYSIS
  • 4.2.1. BUYERS POWER
  • 4.2.2. SUPPLIERS POWER
  • 4.2.3. SUBSTITUTION
  • 4.2.4. NEW ENTRANTS
  • 4.2.5. INDUSTRY RIVALRY
• 4.3. GROWTH PROSPECT MAPPING
• 4.4. MARKET CONCENTRATION ANALYSIS
• 4.5. MARKET MATURITY ANALYSIS

5. MARKET BY COMPONENT

• 5.1. SOLUTION
  • 5.1.1. TRANSPORTATION MANAGEMENT SYSTEM
  • 5.1.2. PLANNING & ANALYTICS
  • 5.1.3. WAREHOUSE & INVENTORY MANAGEMENT SYSTEM
  • 5.1.4. PROCUREMENT & SOURCING
  • 5.1.5. MANUFACTURING EXECUTION SYSTEM
• 5.2. SERVICE
  • 5.2.1. PROFESSIONAL SERVICES
  • 5.2.2. MANAGED SERVICES

6. MARKET BY DEPLOYMENT MODE

• 6.1. ON-PREMISE
• 6.2. CLOUD-BASED

7. GEOGRAPHICAL ANALYSIS

• 7.1. NORTH AMERICA
  • 7.1.1. MARKET SIZE & ESTIMATES
  • 7.1.2. NORTH AMERICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET DRIVERS
  • 7.1.3. NORTH AMERICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET CHALLENGES
  • 7.1.4. NORTH AMERICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET REGULATORY FRAMEWORK
  • 7.1.5. KEY PLAYERS IN NORTH AMERICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET
  • 7.1.6. COUNTRY ANALYSIS
    • 7.1.6.1. UNITED STATES
    • 7.1.6.1.1. UNITED STATES PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES
    • 7.1.6.2. CANADA
    • 7.1.6.2.1. CANADA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES
• 7.2. EUROPE
  • 7.2.1. MARKET SIZE & ESTIMATES
  • 7.2.2. EUROPE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET DRIVERS
  • 7.2.3. EUROPE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET CHALLENGES
  • 7.2.4. EUROPE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET REGULATORY FRAMEWORK
  • 7.2.5. KEY PLAYERS IN EUROPE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET
  • 7.2.6. COUNTRY ANALYSIS
    • 7.2.6.1. UNITED KINGDOM
    • 7.2.6.1.1. UNITED KINGDOM PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES
    • 7.2.6.2. GERMANY
    • 7.2.6.2.1. GERMANY PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES
    • 7.2.6.3. FRANCE
    • 7.2.6.3.1. FRANCE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES
    • 7.2.6.4. ITALY
    • 7.2.6.4.1. ITALY PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES
    • 7.2.6.5. SPAIN
    • 7.2.6.5.1. SPAIN PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES
    • 7.2.6.6. NORDIC COUNTRIES
    • 7.2.6.6.1. NORDIC COUNTRIES PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES
    • 7.2.6.7. REST OF EUROPE
    • 7.2.6.7.1. REST OF EUROPE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES
• 7.3. ASIA-PACIFIC
  • 7.3.1. MARKET SIZE & ESTIMATES
  • 7.3.2. ASIA-PACIFIC PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET DRIVERS
  • 7.3.3. ASIA-PACIFIC PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET CHALLENGES
  • 7.3.4. ASIA-PACIFIC PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET REGULATORY FRAMEWORK
  • 7.3.5. KEY PLAYERS IN ASIA-PACIFIC PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET
  • 7.3.6. COUNTRY ANALYSIS
    • 7.3.6.1. CHINA
    • 7.3.6.1.1. CHINA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES
    • 7.3.6.2. JAPAN
    • 7.3.6.2.1. JAPAN PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES
    • 7.3.6.3. INDIA
    • 7.3.6.3.1. INDIA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES
    • 7.3.6.4. SOUTH KOREA
    • 7.3.6.4.1. SOUTH KOREA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES
    • 7.3.6.5. AUSTRALIA & NEW ZEALAND
    • 7.3.6.5.1. AUSTRALIA & NEW ZEALAND PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES
    • 7.3.6.6. REST OF ASIA-PACIFIC
    • 7.3.6.6.1. REST OF ASIA-PACIFIC PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES
• 7.4. REST OF WORLD
  • 7.4.1. MARKET SIZE & ESTIMATES
  • 7.4.2. REST OF WORLD PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET DRIVERS
  • 7.4.3. REST OF WORLD PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET CHALLENGES
  • 7.4.4. REST OF WORLD PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET REGULATORY FRAMEWORK
  • 7.4.5. KEY PLAYERS IN REST OF WORLD PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET
  • 7.4.6. REGIONAL ANALYSIS
    • 7.4.6.1. LATIN AMERICA
    • 7.4.6.1.1. LATIN AMERICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES
    • 7.4.6.2. MIDDLE EAST & AFRICA
    • 7.4.6.2.1. MIDDLE EAST & AFRICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES

8. COMPETITIVE LANDSCAPE

• 8.1. KEY STRATEGIC DEVELOPMENTS
  • 8.1.1. PRODUCT LAUNCHES
  • 8.1.2. PARTNERSHIPS
• 8.2. COMPANY PROFILES
  • 8.2.1. ARVATO SUPPLY CHAIN SOLUTIONS
    • 8.2.1.1. COMPANY OVERVIEW
    • 8.2.1.2. PRODUCTS / SERVICES LIST
  • 8.2.2. CARDINAL HEALTH
    • 8.2.2.1. COMPANY OVERVIEW
    • 8.2.2.2. PRODUCTS / SERVICES LIST
    • 8.2.2.3. STRENGTHS & CHALLENGES
  • 8.2.3. EPICOR SOFTWARE CORPORATION
    • 8.2.3.1. COMPANY OVERVIEW
    • 8.2.3.2. PRODUCTS / SERVICES LIST
  • 8.2.4. GLOBAL HEALTHCARE EXCHANGE LLC
    • 8.2.4.1. COMPANY OVERVIEW
    • 8.2.4.2. PRODUCTS / SERVICES LIST
    • 8.2.4.3. STRENGTHS & CHALLENGES
  • 8.2.5. INFOR
    • 8.2.5.1. COMPANY OVERVIEW
    • 8.2.5.2. PRODUCTS / SERVICES LIST
    • 8.2.5.3. STRENGTHS & CHALLENGES
  • 8.2.6. JUMP TECHNOLOGIES
    • 8.2.6.1. COMPANY OVERVIEW
    • 8.2.6.2. PRODUCTS / SERVICES LIST
  • 8.2.7. LOGITAG SYSTEMS
    • 8.2.7.1. COMPANY OVERVIEW
    • 8.2.7.2. PRODUCTS / SERVICES LIST
  • 8.2.8. MANHATTAN ASSOCIATES
    • 8.2.8.1. COMPANY OVERVIEW
    • 8.2.8.2. PRODUCTS / SERVICES LIST
    • 8.2.8.3. STRENGTHS & CHALLENGES
  • 8.2.9. MCKESSON CORPORATION
    • 8.2.9.1. COMPANY OVERVIEW
    • 8.2.9.2. PRODUCTS / SERVICES LIST
    • 8.2.9.3. STRENGTHS & CHALLENGES
  • 8.2.10. ORACLE CORPORATION
    • 8.2.10.1. COMPANY OVERVIEW
    • 8.2.10.2. PRODUCTS / SERVICES LIST
    • 8.2.10.3. STRENGTHS & CHALLENGES
  • 8.2.11. SAP SE
    • 8.2.11.1. COMPANY OVERVIEW
    • 8.2.11.2. PRODUCTS / SERVICES LIST
    • 8.2.11.3. STRENGTHS & CHALLENGES
  • 8.2.12. SPECTRUM HEALTH
    • 8.2.12.1. COMPANY OVERVIEW
    • 8.2.12.2. PRODUCTS / SERVICES LIST
  • 8.2.13. TECSYS INC
    • 8.2.13.1. COMPANY OVERVIEW
    • 8.2.13.2. PRODUCTS / SERVICES LIST
    • 8.2.13.3. STRENGTHS & CHALLENGES
  • 8.2.14. TERSO SOLUTION
    • 8.2.14.1. COMPANY OVERVIEW
    • 8.2.14.2. PRODUCTS / SERVICES LIST
    • 8.2.14.3. STRENGTHS & CHALLENGES
  • 8.2.15. VIZIENT INC
    • 8.2.15.1. COMPANY OVERVIEW
    • 8.2.15.2. PRODUCTS / SERVICES LIST